May 16, 20246 min read
Feb 6, 20243 min read
top of page
Crack Open the Mysteries of Weight Loss Medications
Welcome to PoundsPunch!
PoundsPunch isn't just about information; it's about empowerment. I aim to provide straightforward and fun guidance, demystifying the weight loss drug business so that individuals like you and I can make informed choices and get the help we need.
Click here to know more
PoundsPunch Periodical 2025.05: Novo Nordisk CEO Shake-Ups and Formularies on Fire in the Obesity-Drug Wars
Novo Nordisk ousted its longtime CEO just two weeks after scoring a major win with CVS Caremark, which named Wegovy its preferred weight-loss drug and dropped Eli Lilly’s Zepbound. But Lilly isn’t flinching. CEO David Ricks dismissed the move as “last decade,” signaling a shift away from exclusive PBM deals and toward direct-to-consumer access. As manufacturers double down on digital pharmacies and price cuts, the real fight for the obesity market may be happening outside the
PoundsPunch Periodical 2024.04: "Orforglipron??" Why Weight-Loss Drugs Names Sound Like Wi-Fi Passwords
Why do weight-loss drugs have names like Orforglipron? This article breaks down the logic behind drug naming, from science to branding—no jargon, just clarity.
PoundsPunch Periodical 2025.03: The Gray Market for "Research Use Only" Weight Loss Drugs
Experimental weight loss drugs are being sold online for "research use only"—but many are injecting them at home.
Nov 19, 20242 min read
Nov 19, 20244 min read
Sep 26, 20244 min read
Recent Articles
PoundsPunch Periodical 2025.05: Novo Nordisk CEO Shake-Ups and Formularies on Fire in the Obesity-Drug Wars
Novo Nordisk ousted its longtime CEO just two weeks after scoring a major win with CVS Caremark, which named Wegovy its preferred weight-loss drug and dropped Eli Lilly’s Zepbound. But Lilly isn’t flinching. CEO David Ricks dismissed the move as “last decade,” signaling a shift away from exclusive PBM deals and toward direct-to-consumer access. As manufacturers double down on digital pharmacies and price cuts, the real fight for the obesity market may be happening outside the
6 hours ago4 min read
PoundsPunch Periodical 2024.04: "Orforglipron??" Why Weight-Loss Drugs Names Sound Like Wi-Fi Passwords
Why do weight-loss drugs have names like Orforglipron? This article breaks down the logic behind drug naming, from science to branding—no jargon, just clarity.
Apr 243 min read
PoundsPunch Periodical 2025.03: The Gray Market for "Research Use Only" Weight Loss Drugs
Experimental weight loss drugs are being sold online for "research use only"—but many are injecting them at home.
Mar 303 min read
PoundsPunch Periodical 2025.02: FDA Cracks Down on Compounded Semaglutide, Eli Lilly Slashes Zepbound Prices, and Insurance Struggles Continue
FDA Cracks Down on Compounded Semaglutide, Eli Lilly Slashes Zepbound Prices, and Insurance Struggles Continue
Feb 282 min read
May 16, 20246 min read
May 15, 20246 min read
May 15, 20243 min read
May 13, 20246 min read
bottom of page